The Pennant Group (PNTG) Investor presentation summary

Market position and growth drivers

• Operates in a large, expanding market with strong demographic tailwinds from an aging US population, fueling demand for home health, hospice, and senior living services.

• Employs a decentralized operating model empowering local leaders, resulting in superior clinical, financial, and community outcomes.

• Achieved a 31.9% revenue CAGR and 33.4% consolidated adjusted EBITDA CAGR from 2023 to 2025, demonstrating robust growth.

• Maintains a diversified portfolio with balanced revenue streams from home health, hospice, and senior living segments.

• Focuses on organic growth, talent development, and disciplined acquisitions in highly fragmented markets.

Financial performance and stability

• 2026 YTD revenue reached $583.3 million, with $466.8 million from home health & hospice and $116.5 million from senior living.

• Consolidated adjusted EBITDA margin improved from 7.6% in 2023 to 7.9% in 2026, reflecting operational efficiency.

• Maintains a strong balance sheet with $201.9 million drawn on a $350 million debt facility and $160.8 million in acquisition firepower as of June 2026.

• Net debt to LTM consolidated adjusted EBITDA at 2.1x and lease-adjusted leverage at 4.3x as of June 2026.

• Cost of services and general & administrative expenses represent over 94% of operating expenses in 2026.

Operational excellence and quality

• Average 4.1 star rating for home health vs. national average of 3.0; hospice process measure composite score of 98.1% vs. 91.7% national average.

• Lower hospitalization rates for home health patients compared to national median.

• Strong community partnerships and referral networks with hospitals, physicians, and senior living providers.

• Innovative use of technology and centralized support services enhance care delivery and operational efficiency.

• Favorable long-term lease agreements with a weighted average remaining lease tenor of 10.7 years and strong lease coverage ratios.